Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease
NCT06903910Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Nov 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of donepezil in Parkinson's disease (PD), sponsored by University of Virginia. Started Nov 2024; status: completed.
02
Drugs
donepezil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06903910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06903910.